ITV I'm A Celebrity fans all say the same thing as Coleen Rooney screams in terrorStrategic curiositysuper ace apk 。

There's a new hockey league aiming to keep more women on the iceAcademy Sports to Buy Back Up to $700M in Stock

AP Top 25: Alabama, Mississippi out of top 10 and Miami, SMU are in; Oregon remains unanimous No. 1Out of Reconciliation: Remembering The Daughter Of Destiny

Netflix viewers are raving about a 'ten out of ten' action thriller that's garnering high praise on the streaming service. The 2009 film, Law Abiding Citizen, stars Gerard Butler and is helmed by F. Gary Gray, known for his work on Straight Outta Compton and The Italian Job. Penned by Kurt Wimmer, the director behind sci-fi hits like Equilibrium, UltraViolet and the 2020 remake of Children of the Corn, the film centres around Butler's character, Clyde Shelton. He's on a relentless quest for vengeance against those who brutally murdered his wife and daughter during a home invasion. But his wrath isn't just reserved for the killers - he also targets the law enforcement officials, including attorney Nick Rice, portrayed by Jamie Foxx, who failed to deliver the justice Clyde so desperately sought, reports the Mirror . Fans have been effusive in their praise for the film, with many taking to social media to recommend it. One viewer enthused: "'Law Abiding Citizen is a top 10 movie of all time." A Christmas film with a 97% Rotten Tomatoes score dubbed 'new classic' One of the 'greatest films of all time' that won seven Oscars showing free on TV tonight Another chimed in: 'Law Abiding Citizen is almost a classic film and its performance by Gerard Butler is Oscar-worthy." A third fan declared: "Law Abiding Citizen is one of the greatest movies ever made. Real cinema" while another described it as a "phenomenal movie" that "doesn't get enough credit", labelling it "top tier". Netflix is gearing up to premiere another edge-of-your-seat action thriller, Carry-On, set for release on December 13. The film features Taron Egerton as Ethan Kopek, a security agent who becomes entangled with a mysterious traveller, played by Jason Bateman, communicating through an earpiece.In a sinister turn of events, the traveller blackmails Ethan into sneaking an ominous package through airport security, endangering the lives of everyone aboard a Christmas Eve flight. The trailer teases an intense battle of wits, with Ethan desperately trying to out manoeuvre the villain's deadly plan. Fans on Reddit have been expressing their anticipation, with one fan writing: "This could be a treat. Evil Bateman is the best Bateman." Another concurred, "So agree! I love all JB.He's a hard worker, but I really love his evil. Reminiscent of Gene Hackman to me." A third adds, "Looks very interesting. Good timing too, with many people flying for the holidays. I'll be watching it as soon as it is released."

Doctors have raised concerns about a “dangerous” weight-loss black market after The i Paper found second-hand prescription drugs being advertised on Facebook. Ozempic and Mounjaro were among the medicines – which are only available in the UK via a prescription – that were seen promoted for sale in weight-loss groups on the social media platform. The drugs have soared in popularity after Elon Musk, Jeremy Clarkson and a slew of other celebrities said they had lost weight after taking them. Ozempic, one of several brands that contain semaglutide, and Mounjaro, which contains tirzepatide, are administered via injection of pre-filled pens. They work by mimicking the hormone glucagon-like peptide-1, which is released after eating, and suppresses a patient’s appetite. The National Institute of Health and Care Excellence (Nice) recommends semaglutide for adults who have at least one weight-related comorbidity and a body mass index (BMI) score of at least 35, or a BMI of at least 30 and meet criteria for referral to a specialist weight management service. People with a BMI score between 30 and 39.9 are classified as obese, with those scoring 40 and above deemed severely obese. Ozempic is only approved for the management of diabetes but can be prescribed off-label to aid weight loss. Mounjaro is only approved on the NHS to treat diabetes. It is mainly aimed at those with a BMI of at least 35 but can be prescribed to people with a lower BMI if they meet other criteria. The restrictions around the medicines and their wonder-drug status has led to them being highly sought after by people who want to lose weight but do not qualify for them via the NHS. Several posts seen by The i Paper show Facebook users are using the platform to exploit the hype of the drugs and sell them on the black market. It is illegal to advertise prescription-only medicines to the public, sell them outside legitimate supply chains or for patients to sell prescription drugs to others. Patients who want to get rid of medicines they no longer need or want are encouraged to take them to a pharmacy so they can be disposed of safely. Under Facebook’s parent company Meta’s regulated goods policy, users are not allowed to post content about weight loss that contains a miracle claim and attempts to buy, sell, trade, donate or gift weight loss products. Some buyers are being courted by sellers after posting in search of advice on where to buy the drug cheaply or after complaining of shortages. One member in a UK weight loss group wrote: “There’s a possibility I won’t be able to buy my next pen after this one due to my husband being laid off work just before Christmas. I’m starting my 5mg pen on Monday which takes me to 30th December if using 5th dose, if I was to take a month or two break, do I then restart at 2.5mg or will they let me pick up where I left off? Maybe 5mg though rather than 7.5mg.” Another user responded: “Ive got 2 for sale cheap [sic]”. The author of the original post replied: “Oh yes please!” One prospective buyer said she bought Mounjaro from a UK online pharmacy but they are struggling to fulfill the prescription. She continued: “I’m sure it will arrive as soon as they get stock but I’m reluctant to buy my next pen from them – I don’t want to have to stop/start... Can anyone recommend another provider?” Some members of weight loss drug-themed Facebook groups complained of being inundated by private messages from people offering to sell them the drug, while others warned against scammers on the platform. Those offering to sell the drug included one member who wrote in a UK group: “I finished with my weight loss journey and unfortunately I stayed with a few boxes of Ozempic in my fridge that the pharmacy will not be able to reimburse me [sic] so whoever is interested can leave me a message”. Another member in the same group said: “I’ve got extra Mounjaro and Ozempic in my refrigerator FDA approved. Pm if you need for improvements”. It comes after The i Paper revealed that 274 hospitalisations have been associated with the increasingly popular slimming injections – far higher than the 68 detailed by the health regulator. The overall number of adverse reactions linked to weight loss jabs has now reached 14,996 – more than double the figure reported by the Medicines and Healthcare products Regulatory Agency (MHRA) only last month. Dr Lizzie Toberty, GP lead at Doctors Association UK, warned that if the NHS does not “quickly catch up” to demand and fund “prompt” access to weight loss drugs “this is the inevitable result”. She said: “Thousands, if not millions of patients are desperate to lose weight, and we now have effective drugs to help, but once again no funding to help them. We urge the Government to urgently review and help these patients. “If not a risky black market will be created with the NHS having to pick up the unintended and serious consequences of patients buying these drugs.” Dr Ellen Welch, vice chair of the Doctors Association UK and vice chair of North Cumbria Local Medical Committee, said a “postcode lottery” exists around access to weight loss injections on the NHS. She said: “We have so many patients who do not fit the criteria for referral to weight loss services, but do need help with obesity. These medications do make a difference and they are being rationed. Read Next Weight-loss jab hospital cases surge by hundreds with online sales blamed “Of course lifestyle measures also need to be part of management but I can’t imagine any other condition where there is a treatment that works that is rationed to the extent patients seek it via the black market.” Professor Kamila Hawthorne, chair of the Royal College of GPs, warned against these drugs being purchased via social media without a prescription, saying: “In many cases people might not actually be getting what they think they are, which is really dangerous. “It can also be a genuine threat to patient safety if drugs are not being used for what they are licensed for – and potentially contributes to supply shortages, for those who could really benefit from them. “We would encourage patients to take caution when accessing medicine online, and only use outlets that follow GMC remote prescribing guidelines and have been approved by the CQC.” Facebook owner Meta and the makers of Ozempic and Mounjaro have been contacted for comment. An Eli Lilly UK spokesperson said: “Patient safety is Lilly’s top priority. Tirzepatide (Mounjaro) should only be used when prescribed by a licensed healthcare professional and prescriptions should be fulfilled and supplied by reputable pharmacies and providers. We provide information about the benefits and risks of all our medicines to regulators around the world. “If anyone is experiencing side effects when taking a Lilly medicine, they should talk to their doctor or other healthcare professional.” A Novo Nordisk statement read: “Patient safety is a top priority for Novo Nordisk, and we are in close dialogue with the Medicines and Healthcare products Regulatory Agency (MHRA) to support patients against falsified products. “Buying prescription-only medicines without a prescription through non-legitimate routes poses a direct danger to health. The contents of the falsified medicines can be entirely different from the genuine medicine and should not be used.”

Giants star WR Malik Nabers (toe) says he's a game-time decisionToday, the art of investment is not any more intimidating pursuit in the hands of Wall Street wizards alone; it’s an adventure for almost anyone willing to explore. Imagine building a portfolio that not only reflects your financial aspirations but also resonates with your values-this is finding your financial fit. With all the new, innovative tools and cutting-edge technology at your fingertips – from stock screeners filtering investments based on your unique criteria to those focused on sustainability, technology, or social impact-now is probably the most seamless journey in the investment landscape ever. So, let’s examine how you can step up your investment game, get your money working for you, and always stay true to who you are. How To Align Your Investments With Right Tools? In an age where technology is reshaping how we manage our finances, finding your financial fit has never been more exciting or accessible. You can create your investment portfolio based on your personal values and areas of tolerance, along with your other financial goals. Whether you are seasoned or just starting out, innovative tools and approaches can help take your investment game to a whole new level, such as using the power of a stock screener. 1. Into the Digital Revolution Thanks to technology, the financial world has entirely changed. The days of studying everything in books and doing manual searches for investments are behind us. There are so many digital tools that make this process easy enough for anyone to get a foot into the stock market. The most significant development is probably the emergence of robo-advisors. These automated platforms evaluate your situation and goals, then create and manage an optimized diversified portfolio customized for you. They will invest on your behalf with little effort on your part, thus ideal for those who have always wanted to set up a passive strategy. In addition, many robo-advisors include socially responsible investing. 2. Filter Stocks With Stock Screeners Stock screens are among the most important tools for any investor. This is an efficient tool that filters stocks on specific criteria, thus making a selection easier or finding an investment running in line with your strategy. It lets you set parameters based on market capitalization, dividend yield, price-to-earnings ratio, and even ESG scores. That helps you concentrate on stocks that align with your financial goals and ethical considerations. For example, if you are interested in sustainability, you can screen for companies with high ESG ratings. Therefore, you can invest in businesses that may give financial returns but simultaneously help society. 3. Emerging Investment Strategies While investing, consider new strategies that reflect the current trends people in the market find popular. Here are a few of them for you to consider: 1. Thematic Investing: This investing style focuses on sectors or trends and not specifically on particular sectors. It could be companies associated with telehealth, renewable energy, or cybersecurity, for instance. Doing this helps you invest in areas with substantial growth and align your portfolio with the current trend of interest. 2. Impact Investing: Impact investing tends to share a striking similarity with SRI: it combines financial returns with measurable social or environmental benefits. It is an attractive strategy for individuals who want their investments to support causes that matter to them, whether that is education, health, climate action, or something else. 3. Fractional Shares: Because of fractional share investing, you do not necessarily have to save much money to buy expensive stocks. You can diversify your portfolio even if you do not have a huge savings account because you will acquire fractions of shares from those gigantic companies. So it will not be challenging to spread your investments in different sectors. 4. Leverage Data and Analytics Data-driven decision-making has also become an essential part of investing today. Most platforms provide analytics tools, which provide insights into market trends and stock performance. One can access real-time data, historical performance metrics, and even sentiment analysis, which drives decisions accordingly. You can, therefore, use these tools to make informed decisions that may eradicate possible risks. You can perfectly analyze your data and show all the chances you would otherwise not recognize. 5. Building a Community Another amazing feature of modern investing is the ability to build a sense of community through technology. One can easily connect with fellow investors, gain insights, and learn on forums, social media groups, or even through investment applications. Connecting with like-minded people may also provide support, accountability, and inspiration when navigating your financial journey. Discussions about stock picks, investment strategies, and market trends abound on platforms like Reddit and Twitter, and specific online forums are dedicated to investing. Joining these communities can increase your knowledge and confidence, turning you into a more well-informed investor. Finding the perfect financial fit requires being current about various financial news and trends. Subscription to financial news websites, investment newsletters, and market analysis blogs provides precious insight into the financial landscape, keeping one on top. Participation in webinars and virtual investment conferences also helps deepen your understanding of various investment strategies and tools. As you embark on this journey, remember to be patient and flexible. The investment landscape continues to evolve, so you will continue learning and maturing throughout your journey. It is possible to develop a portfolio that not only aims for financial success but also corresponds with your values and your belief in using the right tools and staying informed. Happy investing!Azealia Banks Sends Cease & Desist Letter to Matty Healy Demanding $1 Million in Damages

H&M CELEBRATES NEW STORE WITH CHRISTINA AGUILERA NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Today at noon, H&M celebrated the reopening of its iconic Times Square flagship, located at 1472 Broadway, with a special appearance and ribbon cutting ceremony with global pop superstar Christina Aguilera . The refined space, featuring elevated aesthetics and materials, includes immersive experiences showcasing the very best of the brand's fashion identity. At the time of opening, the store will showcase a variety of fashion-forward collections including the H&M Studio Holiday Capsule, which was launched in select stores and online today, offering a modern take on partywear. The store caps off a season of investment and reignited direction for the Swedish brand in its U.S. home of New York City . "I am so excited to be here at H&M's gorgeous new store, in Times Square no less," said Christina Aguilera . "What perfect timing for this location to reopen with their new collection just before the start of the holiday season. We're very excited to bring on the joy for the season!" This fall, H&M celebrates the launch of its most impressive season of fashion yet, which will be on full display at the new Times Square store. The fully redesigned flagship is an elevated, dynamic space featuring women's and men's collections, including special shop-in-shop destinations for H&M Move, the brand's sport offering, as well as denim, lingerie, and accessories. The location will also carry clothing for children ranging from newborn to 10 years old. "H&M debuted in the US nearly 25 years ago with a flagship location in New York City . As a pivotal city for our brand, we continue to invest in our NYC stores to ensure they remain cutting-edge and inspirational to our ever-evolving customer," says Michael Beaumont , Regional Head of Expansion for H&M Americas. "With this refreshed flagship store, customers will be able to see and feel H&M's strengthened brand identity firsthand through hyper-curated artistic and design elements, innovative technologies, and interactive experiences — all anchored by H&M's diverse fashion offerings." The focus on customer experience is reflected in the brand-new immersive fitting area, a first in North America , where fashion lovers can explore trends, try on looks, and bring their style dreams to life. The fitting rooms, a first offer a customizable, multi-sensory experience with LED screens in the floor and ceiling, along with interactive mirrors. Customers can express themselves by selecting visual themes and music based on their style choices and moods, making the shopping experience more personalized and engaging. With visuals and music curated specifically for the new store, these rooms will also encourage customers to create and share their own content. "Our Times Square location is an amazing new space for customers to interact with our brand as well as each other," says Linda Li , Head of Customer Activation and Marketing for H&M Americas. "Features like our new immersive fitting rooms combine music, fashion and fun to let our customers become their own style star." The redesigned flagship showcases impressive new design features like an iconic glass wall flanking each side of the main escalator, designed by Denver based agency, Hovercraft. This signature piece combines art and technology into a multi-story ambient light display, providing customers with a dazzling show on their way to the upper levels. Other interior upgrades include fluted concrete panels, seamless terrazzo flooring, custom built wood fitting rooms and two enormous LED screens on the ground and second floor. Contact: [email protected] For more images of the opening and new store, click here . For more information from the H&M group and press images visit hmgroup.com/media SOURCE H&MWASHINGTON — President-elect Donald Trump said Wednesday that he has selected a former soldier and Iraq War veteran to serve as his secretary of the Army . Daniel P. Driscoll, who is from North Carolina, had been serving as a senior advisor to Vice President-elect JD Vance, whom he met when both were attending Yale Law School. He ran unsuccessfully in the Republican primary for a North Carolina congressional seat in 2020, getting about 8% of the vote in a crowded field of candidates. “Dan will be a fearless and relentless fighter for America’s Soldiers and the America First agenda,” Trump said on his social media platform. If confirmed, Driscoll, 38, would take the helm of a military branch that has been struggling to overcome recruiting shortfalls through a sweeping overhaul of its programs and staffing. The Army is also undertaking a widespread effort to revamp and modernize its weapons systems. Since his graduation from Yale in 2014 and his tour in the Army, Driscoll has worked at several investment banking and consulting firms in North Carolina. According to the Army, Driscoll served as an armor officer from August 2007 to March 2011, deploying to Iraq from October 2009 to July 2010. He completed Army Ranger school, earning a Ranger tab, but it was not immediately clear when that occurred. Completing the course allows a soldier to wear the tab but does not mean that he served as a Ranger in the elite 75th Ranger Regiment, which is part of the Army’s special operations command and requires significantly more training. He left the military service at the rank of first lieutenant. He also graduated from the University of North Carolina at Chapel Hill. Driscoll’s military awards include the Army Commendation Medal and the the combat action badge, which are meritoriously earned. His other awards are often given due to completion of service during a military campaign and include National Defense Service Medal, Iraq Campaign Medal with campaign star, Global War on Terrorism Service Medal, Army Service Ribbon, and the Overseas Service Ribbon.

Liverpool boss Arne Slot hailed “special” Mohamed Salah after seeing him fire the Premier League leaders to the brink of victory at Newcastle. The Reds ultimately left St James’ Park with only a point after Fabian Schar snatched a 3-3 draw at the end of a pulsating encounter, but Salah’s double – his 14th and 15th goals of the season – transformed a 2-1 deficit into a 3-2 lead before the Switzerland defender’s late intervention. The 32-year-old Egypt international’s future at Anfield remains a topic of debate with his current contract running down. Asked about Salah’s future, Slot said: “It’s difficult for me to predict the long-term future, but the only thing I can expect or predict is that he is in a very good place at the moment. Two goals and an assist for Mo tonight 👏 pic.twitter.com/tMXidgeA0P — Liverpool FC (@LFC) December 4, 2024 “He plays in a very good team that provides him with good opportunities and then he is able to do special things. “And what makes him for me even more special is that in the first hour or before we scored to make it 1-1, you thought, ‘He’s not playing his best game today’, and to then come up with a half-hour or 45 minutes – I don’t know how long it was – afterwards with an assist, two goals, having a shot on the bar, being a constant threat, that is something not many players can do if they’ve played the first hour like he did. “That is also what makes him special. If you just look at the goals, his finish is so clinical. He’s a special player, but that’s what we all know.” Salah did indeed endure a quiet opening 45 minutes by his standards and it was the Magpies who went in at the break a goal to the good after Alexander Isak’s stunning 35th-minute finish. Slot said: “The shot from Isak, I don’t even know if Caoimh (keeper Caoimhin Kelleher) saw that ball, as hard as it was.” Salah set up Curtis Jones to level five minutes into the second half and after Anthony Gordon has restored the hosts’ lead, levelled himself from substitute Trent Alexander-Arnold’s 68th-minute cross. He looked to have won it with a fine turn and finish – his ninth goal in seven league games – seven minutes from time, only for Schar to pounce from a tight angle in the 90th minute. Newcastle head coach Eddie Howe was delighted with the way his team took the game to the Reds four days after their disappointing 1-1 draw at Crystal Palace. Howe, who admitted his surprise that VAR official Stuart Attwell had not taken a dimmer view of a Virgil van Dijk shoulder barge on Gordon, said: “It’s mixed emotions. “Part of me feels we should have won it – a big part of me – but part of me is pleased we didn’t lose either because it was such a late goal for us. “Generally, I’m just pleased with the performance. There was much more attacking output, a much better feel about the team. “There was much better energy, and it was a really good performance against, for me, the best team we’ve played so far this season in the Premier League, so it was a big jump forward for us.”

NEW YORK, Dec. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. XRAY between December 1, 2022 and November 6, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025 . SO WHAT: If you purchased Dentsply common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a direct-to-consumer ("DTC") aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the U.S. Food and Drug Administration ("FDA"); (6) Dentsply had no systems in place to notify the FDA of these injuries, which Dentsply is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; and (9) as a result of the above, defendants' positive statements about Dentsply's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. ______________________ Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.519 FUTA graduates bag first class

None